yurveda-Based Enema to Support People with Irritable Bowel Syndrome.

A Single Arm Clinical Study to Assess the efficacy of Priyangvadibasti in Grahanidosha with Special Reference to Irritable Bowel Syndrome. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085032

Enrollment

Registered

2025-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients suitable for Basti Karma Patients of either sex in the age group of above 18 years and below 60 years. Patient with classical signs and symptoms of Grahani (~IBS), i.e. Muhur Baddha/Drava Mala Pravritti, Picchila/Durgandhit Mala Pravrittu, Vidaha etc Uncomplicated cases with classical pictures of Grahanidosha will be selected irrespective of sex, caste, religion and profession

Exclusion criteria

Exclusion criteria: Patient having age below 18 years and above 60 years. Patients suffering from Acute Diarrhea, Gastric and Peptic Ulcers, uncontrolled D.M. and H.T. Patients with bleeding per rectum. Pregnant and lactating women. Mixed infection with parasites like round worms, hook worms etc. Patients with evidence of malignancy. Ulcerative colitis, Malabsorption syndrome, I, Intestinal tuberculosis. Patients suffering from major systemic illness like cancer, crohn s disease, renal failure. Patients who are taking corticosteroids, antidepressants, anticholinergic, or any other drugs that may have an influence on the outcome of study. Alcoholics and drug abusers. Other chronic debilitating disease like STD etc Patients who have completed participation in any other clinical trial during the past six months

Design outcomes

Primary

Measure	Time frame
Change in sign and symptoms of disease like Muhur Baddha, Muhur Drava Malapravritti, Ama etcTimepoint: Day 0 and Day 23 and Day 53	—

Secondary

Measure	Time frame
Change in Urine R/M, LFT, ESR.Timepoint: Day 0 and Day 23 and Day 53	—

Countries

India

Contacts

Public ContactDr Fatemeh Moazzamipeiro

National Institute Of Ayurveda Deemed University

guptadr.nisha@gmail.com9828087640

Outcome results